ChromaDex launches largest serving of Tru Niagen through licensed practitioners
ChromaDex Corp. has launched Tru Niagen Pro 500, the largest daily serving of its patented nicotinamide riboside.
Photo © iStockphoto.com/Saklakova
ChromaDex Corp. (Los Angeles, CA) has launched Tru Niagen Pro 500, the largest daily serving of its patented nicotinamide riboside (NR). The product will be exclusively available through licensed healthcare practitioners in the United States.
“This new product will allow practitioners to provide a unique product to their patients who want more energy and improved cellular health,” said ChromaDex CEO Rob Fried, in a press release.
“We are pleased to launch this new product exclusively through the healthcare practitioner channel,” added ChromaDex chief scientific officer Matthew Roberts, PhD. “This new product launch marks a major milestone in a year already characterized by several new significant scientific publications, human clinical data, and regulatory approvals around the world for ChromaDex.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
